August 26, 2016 7:57am

When advancing through a hostile market

… There are no set "right" ways

 

To clear a path through high volatility and low volume, pick your targets by checking the pivot points

… Oversold breakouts are “within reason”

 

Companies in my headlights: AGTC, BLUE, CLLS and XON

Futures are DOWN and indexes (IWM, XBI and XLV) are NOT indicating but, the IBB is UP

 

I answer one question; in which company should investors put, keep and commit their money!

 

Where is today’s market going? 

Subscribe and find out! 

 


 

Where do investors turn for insight and perspective - I say what others won't, so you can do what others can't!

 

 

Indexes and ETFs: The IBB (+0.17%) is UP and the XBI, IWM and the XLV are NOT indicating  

The Dow futures are DOWN -0.03% and NASDAQ futures are DOWN -0.06%

 

U.S. stock index futures indicated a lower open on Friday as traders anticipated Fed Chair Janet Yellen's speech in Jackson Hole, Wyoming.

  • Yellen is set to speak at the Federal Reserve Bank of Kansas City Economic Symposium at 10 a.m. ET, and traders will be watching as to whether she gives any indications on rate hikes.

     

European stocks were flat as investors remain on the sidelines amid continued debate among Federal Reserve officials over the timing of a U.S. rate hike

Asia markets closed mostly lower, with Japanese stocks selling off more than 1% after soft inflation data prompted concerns over the effectiveness of government stimulus.

 

Data docket: Revisions to Q2 GDP are set to come out at 8:30 a.m. ET. International trade data is also due at 8:30 a.m., with consumer sentiment released at 10:00 a.m.

 

 

The stem, cell, gene and regenerative therapy (SCG&RT) sector closed NEGATIVE on Thursday, Wednesday and Tuesday, POSITIVE on Monday and NEGATIVE last Friday.

The SCG&RT sector’s record after the last 5 days (of 43 covered companies):

  • Thursday closed NEGATIVE with 29 decliners, 13 advancers and 1 flat;
  • Wednesday closed NEGATIVE with 35 decliners, 5 advancers and 3 flats;
  • Tuesday closed NEGATIVE with 28 decliners, 14 advancers and 1 flat;
  • Monday closed POSITIVE with 14 decliners, 27 advancers and 2 flats;
  • Last Friday closed NEGATIVE with 29 decliners, 13 advancers and 1 flat;

 

 

Remembering Thursday’s closing post, “Crosscurrents infect the sector. Big drop at 2 p.m. as sellers and buyers catch “conflicting tendency” fever. Speculation fuels the tape as Friday’s “economic event” and the summer weekend approach.”

  • The sector and market are oversold and basically on hold until Fed’s head Janet Yellen addresses the masses today in Jackson Hole, Wyo.

 Yellen’s speech will spark either a breakout or a downside reversal. Which one occurs will be very important going forward.

  • It would pay to take a risk by paying attention to the mornings “wandering” indexes, futures and patterns which should be watched for a clear indication – I believe Yellen will hold back on any rate decision.

I’d be aware of the IBB and IWM and its beginnings this a.m.!

  • I believe, “our” universe’s pricing is ripening for an uptick for the oversold

I’m still holding on to “some” equities, recommending selling others and sticking my head in the sand until after Labor Day!

 

 

You’ve made it to the office, turned on the monitor, having just gotten your coffee and it hits you - what could be today’s trades? 

Watch list:

  • The iShares Nasdaq Biotechnology (IBB) closed Thursday down 1.11% after Wednesday’s -3.36% and is UP +0.17% in Friday’s pre-market;
  • The SPDR S&P Biotech ETF (XBI) closed Thursday down -1.06% and is NOT indicating in Friday’s  pre-market;
  • The Health Care Select Sector SPDR ETF (XLV) closed down Thursday -0.84% and is NOT indicating in Friday’s pre-market;
  • The iShares Russell 2000 (IWM) closed up +0.20% on Thursday and is NOT indicating in Friday’s pre-market.

 

 

Companies in my headlights:

Applied Genetic Technologies (AGTC) closed DOWN -$0.28 to $13.40 after Wednesday’s $13.58 (-$1.05) after Tuesday’s $14.63 (-$0.19). It’s been a merry-go-round seven days of trading. The last time we saw a lower close was June 27 at $12.96. I do have concerns that AGTC hasn’t reported financial results/earnings after Fidelity dumped their position and Biogen (BIIB) has been reviewing all internal programs and collaborations. Still, Oversold – Maintaining BUY;

bluebird bio (BLUE) closed DOWN -$0.29 to $49.97 following Wednesday’s $50.26 (-$4.65). The last four day’s pricings are telling; Tuesday’s $54.91, Monday’s $54.71 and last Friday’s $53.73 pricings. The aftermarket is positive +$0.26. Oversold – Maintaining BUY;

Cellectis SA (CLLS) closed DOWN -$0.51 to $26.46 following Wednesday’s $26.97 (-$0.11) after Tuesday’s $27.08 (+$0.43), Monday’s $26.65 after last Friday’s $25.90. The aftermarket indication is positive +$0.79. The aftermarket is positive +$0.27 – Maintaining BUY;

Intrexon (XON) closed DOWN -$0.61 to $25.68 following Wednesday’s $26.29 (-$2.98). The past days, Tuesday’s $29.27, Monday’s $29.27 and last Friday’s $29.84 have not indicated the need for Florida municipalities to address the growing ZIKA menace. The aftermarket indication is positive +$0.03. Oversold – Maintaining BUY

 

 

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.